Sernova Corp. (TSE:SVA - Get Free Report) hit a new 52-week low on Tuesday . The company traded as low as C$0.18 and last traded at C$0.19, with a volume of 1500 shares changing hands. The stock had previously closed at C$0.18.
Sernova Stock Performance
The company has a market capitalization of C$60.57 million, a PE ratio of -1.74 and a beta of 1.35. The company has a current ratio of 0.32, a quick ratio of 18.11 and a debt-to-equity ratio of -4.40. The stock has a fifty day moving average of C$0.20 and a two-hundred day moving average of C$0.23.
About Sernova
(
Get Free Report)
Sernova Corp. operates as a clinical-stage regenerative medicine therapeutics company in Canada. The company focuses on the development and commercialization of regenerative medicine therapeutics, including its proprietary Cell Pouch and associated technologies consisting of therapeutic cells and local cellular immune protection.
Featured Articles
Before you consider Sernova, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Sernova wasn't on the list.
While Sernova currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Need to stretch out your 401K or Roth IRA plan? Use these time-tested investing strategies to grow the monthly retirement income that your stock portfolio generates.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
